Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05191121
Other study ID # 1847023-1
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date February 23, 2022
Est. completion date June 2027

Study information

Verified date January 2022
Source Craig Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Ninety-nine individuals meeting the study's inclusion/exclusion criteria will be enrolled in this study. The objective of this study is to evaluate three different therapeutic approaches to synergistically retrain functional movement patterns of the upper extremities in combination with trunk stabilization to promote neurologic and functional recovery after SCI. Each subject will complete 40 sessions of intervention. Subjects will also complete a Baseline Evaluation (week 0), Re-Evaluation (week 4), Post Treatment Evaluation (week 8), and a Follow-Up Evaluation (week 12).


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 99
Est. completion date June 2027
Est. primary completion date February 2027
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - History of traumatic SCI - Less than 5months post SCI - SCI injury level C1-C8 - SCI categorized as AIS B-D - Currently receiving inpatient rehabilitation at Craig Hospital - Passive range of motion (ROM) within functional limits at wrists, shoulders, and elbows - Demonstrate motor response to electrical stimulation in majority of UE muscle groups below level of injury (tested during screening) - No complicating physical or cognitive conditions (as determined by their physician) that would preclude safe use of electrical stimulation - Able to complete study as an outpatient if discharged from inpatient rehabilitation before completing 40 sessions of training Exclusion Criteria: - Unstable chronic cardiac or respiratory complaints - Current or history of UE contracture or skin pressure injuries that might interfere with intervention - Received Botox injections within the last 3 months - Pregnant - Implanted devices including: pacemaker, spinal cord stimulator, ventriculoperitoneal shunt, deep brain stimulator, or intra-thecal pump.

Study Design


Intervention

Behavioral:
FTP Alone
Participants will be challenged with training speed, weight, limited therapist support, and context variation (e.g., fine motor activities will vary using objects such as cards, dice, coins).
FTP+Con-FES
Participants will be challenged with training speed, weight, limited therapist support, and context variation (e.g., fine motor activities will vary using objects such as cards, dice, coins). Muscle groups will be stimulated at the same time they would be activated naturally in a pre-injury movement pattern utilizing conventional parameter FES.
FTP+WPHF-FES
Participants will be challenged with training speed, weight, limited therapist support, and context variation (e.g., fine motor activities will vary using objects such as cards, dice, coins). Muscle groups will be stimulated at the same time they would be activated naturally in a pre-injury movement pattern utilizing wide pulse, high frequency parameter FES.

Locations

Country Name City State
United States Craig Hospital Englewood Colorado

Sponsors (2)

Lead Sponsor Collaborator
Craig Hospital National Institute on Disability, Independent Living, and Rehabilitation Research

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Capabilities of Upper Extremity Test (CUE-T) 32 item test, each item scored on a 0-4 point scale with total scores ranging from 0-128. Week 0 to Week 12
Secondary Graded Refined Assessment of Strength, Sensibility, and Prehension (GRASSP) This multimodal test measures sensorimotor and prehension function in three domains important in describing arm and hand function Week 0, Week 8, and Week 12
Secondary International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) Sensory Level The ISNCSCI involves a detailed examination to determine the sensory level for the right and left sides. The sensory level is the most caudal, intact dermatome. Scores range from 0-2. The higher the score the more intact the dermatome is. Week 0, Week 8, and Week 12
Secondary International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) Motor Level The ISNCSCI involves a detailed examination to determine motor levels for the right and left sides. The motor level is defined as the lowest key muscle function that has a grade of at least a 3, providing key muscle functions represented by segments above that level are judged to be intact. Scores range from 0-5. The higher the score the more intact the muscle is. Week 0, Week 8, and Week 12
Secondary International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) Neurological Level of Injury The ISNCSCI involves a detailed examination to determine the neurological level of injury. The neurological level of injury refers to the most caudal segment of the cord with intact sensation and antigravity muscle function strength, provided that there is normal sensory and motor function rostrally respectively. The neurological level of injury is the most cephalad of the sensory and motor levels. Week 0, Week 8, and Week 12
Secondary International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) Sacral Sparing The ISNCSCI involves a detailed examination to determine whether a spinal cord injury is complete or incomplete. If an injury is considered complete there is an absence of voluntary anal contraction, absent sensory scores of S4-5, and absence of deep anal pressure. Week 0, Week 8, and Week 12
Secondary International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) Impairment Grade The ISNCSCI involves a detailed examination to determine a spinal cord injury's grade according to the American Spinal Injury Association. Score ranges from A-E. ASIA classification A means spinal injury is considered complete with no sensory or motor function preserved in sacral segments. On the opposite end of the scale an ASIA classification E means 'normal'. Week 0, Week 8, and Week 12
Secondary Pinch Force Pinch force will be measured by the Commander Echo Console with the JTech Pinch Dynamometer to quantify finger strength. Week 0, Week 8, and Week 12
Secondary Grasp Force Grasp force will be measured by the Commander Echo Console with the JTech Hand Dynamometer to quantify grasp strength. Week 0, Week 8, and Week 12
Secondary Modified Functional Reach (MFR) The MFR will be used to measure dynamic trunk stability Week 0, Week 8, and Week 12
Secondary Global Rating of Change (GRC) The Global Rating of Change scale assesses perceived change from an intervention. 9 point Likert scale. Higher positive score reflects great improvement Week 0, Week 8, and Week 12
Secondary NeuroRecovery Scale (NRS) The full NRS comprises of 16items. For the purpose of this upper extremity interventional study, only six items will be used that represent a variety of functional upper extremity movement patterns required for ADL management. These scores will be used to guide treatment across all 3 groups. Scores range from 1A-4C. Higher scores reflect greater recovery of spinal cord injury. Week 0 and Week 4
Secondary Demographic Information Demographic information will include: age, sex, race/ethnic background, pre-injury education, employment status, marital status, and living situation. Week 0
Secondary Injury Information Injury information will include: date of injury, cause of injury, baseline AIS classification, and injury level. Week 0
See also
  Status Clinical Trial Phase
Recruiting NCT05163639 - Spinal Cord Associative Plasticity Study N/A
Recruiting NCT06087445 - A User-friendly, Non-invasive Neuro-orthosis That Restores Volitionally Controlled Grasp Functions for SCI Survivors With Tetraplegia N/A
Terminated NCT02163876 - Study of Human Central Nervous System (CNS) Stem Cell Transplantation in Cervical Spinal Cord Injury Phase 2
Not yet recruiting NCT04688229 - Motor Recovery Training for Hand and Digits in Stroke and SCI N/A
Recruiting NCT06101199 - Combined Therapeutic Air Mixture and Electrical Stimulation to Improve Breathing and Hand Function in Spinal Cord Injury N/A
Not yet recruiting NCT06169696 - EMPOWER Early Feasibility Study: Non-invasive BCI to Control a Wheelchair for People With Paralysis N/A
Completed NCT01963026 - Linking Brain to Behaviour Research in SCI N/A
Active, not recruiting NCT04815967 - Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity Phase 2/Phase 3
Recruiting NCT05665998 - Brain Controlled Spinal Cord Stimulation in Participants With Cervical Spinal Cord Injury for Upper Limb Rehabilitation N/A
Completed NCT05425238 - Blood Flow Restriction Resistance Exercise in Lower Cervical Spinal Cord Injury Patients N/A
Active, not recruiting NCT05360524 - Laminectomy Alone Versus Laminectomy and Fusion for Traumatic Cervical Spinal Cord Injury Without Instability N/A
Completed NCT04183998 - Restorative Neuromodulation for Upper Extremity Functions N/A
Completed NCT02302157 - Dose Escalation Study of AST-OPC1 in Spinal Cord Injury Phase 1/Phase 2
Completed NCT03464409 - Supporting Patient Decisions About UE Surgery in Cervical SCI N/A
Completed NCT05678803 - Short-Term Outcomes Of Subaxial Cervical Injuries
Not yet recruiting NCT06225245 - Augmenting Rehabilitation Outcomes and Functional Neuroplasticity Using Epidural Stimulation of Cervical Spinal Cord N/A
Recruiting NCT05786313 - Study of Individualized, Precise and Standardized Cervical Open-door Surgery for Cervical Spinal Stenosis N/A
Recruiting NCT05638191 - Nerve Transfer Surgery to Restore Upper-limb Function After Cervical Spinal Cord Injury
Not yet recruiting NCT03567902 - C-MAC Videolaryngoscope Intubation and Cervical Spine Motion N/A
Recruiting NCT01579604 - Nerve Transfer Reconstruction in the Tetraplegic Upper Extremity Phase 4